What tumor vessels can tell us.
Coverage on: Helfrich, I., Scheffrahn, I.,Bartling, S., Weis, J., von Felbert, V.,Middleton, M., Kato, M., Ergün, S., and Schadendorf, D. (2010). Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization,and maturation in malignant melanoma. J. Exp. Med. 207, 491-503.
Lee
Sunyoung
S
slee@burnham.org
D000818:Animals; D042783:Endothelial Cells / Q000187:drug effects / Q000473:pathology; D006801:Humans; D051379:Mice; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000098:blood supply* / Q000188:drug therapy; D009389:Neovascularization, Pathologic / Q000188:drug therapy / Q000473:pathology*; D020286:Pericytes / Q000187:drug effects / Q000473:pathology; D010641:Phenotype; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use
D042461:Vascular Endothelial Growth Factor A